Previous research has revealed that fluorofenidone inhibits high glucose and hypertension (Ang II)-induced TGF-β1 expression, and reduces TGF-β1-mediated signaling events in both the proximal tubule epithelial and mesangial cells [17], [15]. This evidence concerns the gene TGFB1 and hypertensive disorder.